BR0010990A - Suspensão de ziprasidona - Google Patents

Suspensão de ziprasidona

Info

Publication number
BR0010990A
BR0010990A BR0010990-8A BR0010990A BR0010990A BR 0010990 A BR0010990 A BR 0010990A BR 0010990 A BR0010990 A BR 0010990A BR 0010990 A BR0010990 A BR 0010990A
Authority
BR
Brazil
Prior art keywords
ziprasidone
suspension
ziprasidona
polysorbate
pharmaceutically acceptable
Prior art date
Application number
BR0010990-8A
Other languages
English (en)
Inventor
Daniel Ray Arenson
Hong Qi
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22472103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0010990(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0010990A publication Critical patent/BR0010990A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Cosmetics (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Colloid Chemistry (AREA)
  • Dental Preparations (AREA)

Abstract

Patente de Invenção: "SUSPENSãO DE ZIPRASIDONA". Composições contendo base livre de ziprasidona ou um sal de adição de ácido farmaceuticamente aceitável de ziprasidona difícil de molhar, um polissorbato e dióxido de silício coloidal formam boas suspensões aquosas possuindo um tempo de armazenamento útil e são facilmente ressuspensas se ocorrer sedimentação.
BR0010990-8A 1999-05-27 2000-05-08 Suspensão de ziprasidona BR0010990A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13626899P 1999-05-27 1999-05-27
PCT/IB2000/000593 WO2000072847A1 (en) 1999-05-27 2000-05-08 Ziprasidone suspension

Publications (1)

Publication Number Publication Date
BR0010990A true BR0010990A (pt) 2002-03-05

Family

ID=22472103

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010990-8A BR0010990A (pt) 1999-05-27 2000-05-08 Suspensão de ziprasidona

Country Status (50)

Country Link
EP (1) EP1181018B1 (pt)
JP (1) JP3942827B2 (pt)
KR (1) KR100477782B1 (pt)
CN (1) CN1196486C (pt)
AP (1) AP1409A (pt)
AR (1) AR022643A1 (pt)
AT (1) ATE234097T1 (pt)
AU (1) AU777413B2 (pt)
BG (1) BG65367B1 (pt)
BR (1) BR0010990A (pt)
CA (1) CA2371550C (pt)
CO (1) CO5170458A1 (pt)
CR (1) CR6506A (pt)
CU (1) CU23223B7 (pt)
CZ (1) CZ20014230A3 (pt)
DE (1) DE60001649T2 (pt)
DK (1) DK1181018T3 (pt)
DZ (1) DZ3049A1 (pt)
EA (1) EA003907B1 (pt)
EE (1) EE04704B1 (pt)
ES (1) ES2191618T3 (pt)
GC (1) GC0000190A (pt)
GE (1) GEP20033113B (pt)
GT (1) GT200000081A (pt)
HK (1) HK1046366B (pt)
HN (1) HN2000000071A (pt)
HR (1) HRP20010878B1 (pt)
HU (1) HUP0201297A3 (pt)
IL (2) IL145950A0 (pt)
IS (1) IS2396B (pt)
MA (1) MA26741A1 (pt)
MX (1) MXPA01012124A (pt)
MY (1) MY127891A (pt)
NO (1) NO320296B1 (pt)
NZ (1) NZ514764A (pt)
OA (1) OA11946A (pt)
PA (1) PA8495801A1 (pt)
PE (1) PE20010127A1 (pt)
PL (1) PL196867B1 (pt)
RS (1) RS50089B (pt)
SI (1) SI1181018T1 (pt)
SK (1) SK284590B6 (pt)
SV (1) SV2001000085A (pt)
TN (1) TNSN00112A1 (pt)
TR (1) TR200103392T2 (pt)
TW (1) TWI263498B (pt)
UA (1) UA59491C2 (pt)
UY (1) UY26166A1 (pt)
WO (1) WO2000072847A1 (pt)
ZA (1) ZA200109692B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7175855B1 (en) 1999-05-27 2007-02-13 Pfizer Inc. Ziprasidone suspension
MXPA02004293A (es) 1999-10-29 2002-10-31 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada..
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CN100518827C (zh) 2000-10-30 2009-07-29 欧罗赛铁克股份有限公司 控释氢可酮制剂
JP4619658B2 (ja) * 2002-03-12 2011-01-26 富山化学工業株式会社 快い味の経口懸濁液および方法
BR0315663A (pt) * 2002-10-25 2005-08-30 Pfizer Prod Inc Formulações de depósito de agentes ativos de aril-heterocìclicos na forma de uma suspensão
BR0315568A (pt) * 2002-10-25 2005-08-23 Pfizer Prod Inc Formulações de depósito injetáveis
EP1418492B1 (en) 2002-11-05 2017-09-20 LG Electronics, Inc. Touch screen mounting assembly for LCD monitor
EP1628973A2 (en) 2003-10-24 2006-03-01 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
US20070237828A1 (en) * 2004-06-11 2007-10-11 Dr. Reddy's Laboratories Limited Ziprasidone Dosage Form
WO2006085168A2 (en) * 2005-01-07 2006-08-17 Ranbaxy Laboratories Limited Solid oral dosage forms of ziprasidone containing colloidal silicone dioxide
EP1901722A4 (en) * 2005-06-20 2011-06-15 Elan Pharma Int Ltd NANOTEHOUS COMPOSITIONS WITH CONTROLLED RELEASE FROM ARYL-HETEROCYCLIC COMPOUNDS
WO2007052289A2 (en) 2005-07-22 2007-05-10 Rubicon Research Pvt Ltd. Novel dispersible tablet composition
CN100391458C (zh) * 2006-02-07 2008-06-04 上海医药工业研究院 齐拉西酮或其盐包合物制备方法
KR20080076667A (ko) * 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
JP4336380B1 (ja) * 2008-11-06 2009-09-30 塩野義製薬株式会社 水懸濁性を向上させた細粒剤
JP6272730B2 (ja) * 2014-05-21 2018-01-31 救急薬品工業株式会社 速溶性フィルム剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5312925A (en) * 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
US6150366A (en) * 1998-06-15 2000-11-21 Pfizer Inc. Ziprasidone formulations

Also Published As

Publication number Publication date
SK284590B6 (sk) 2005-07-01
EP1181018A1 (en) 2002-02-27
CA2371550A1 (en) 2000-12-07
EA003907B1 (ru) 2003-10-30
IL145950A0 (en) 2002-07-25
HN2000000071A (es) 2001-02-02
NO20015755D0 (no) 2001-11-26
AU777413B2 (en) 2004-10-14
AR022643A1 (es) 2002-09-04
CA2371550C (en) 2007-01-02
CR6506A (es) 2004-03-24
PA8495801A1 (es) 2001-12-14
TR200103392T2 (tr) 2002-11-21
SI1181018T1 (en) 2003-06-30
KR20020048307A (ko) 2002-06-22
KR100477782B1 (ko) 2005-03-21
GC0000190A (en) 2006-03-29
BG65367B1 (bg) 2008-04-30
IS6134A (is) 2001-10-30
IL145950A (en) 2007-12-03
HK1046366A1 (en) 2003-01-10
AP1409A (en) 2005-06-13
HRP20010878B1 (en) 2007-03-31
MA26741A1 (fr) 2004-12-20
SK16782001A3 (sk) 2002-09-10
PE20010127A1 (es) 2001-02-06
EE200100633A (et) 2003-02-17
UY26166A1 (es) 2000-12-29
JP3942827B2 (ja) 2007-07-11
ES2191618T3 (es) 2003-09-16
AP2001002346A0 (en) 2001-12-31
CZ20014230A3 (cs) 2002-08-14
NZ514764A (en) 2004-04-30
SV2001000085A (es) 2001-11-08
DE60001649T2 (de) 2003-08-21
CN1352560A (zh) 2002-06-05
NO20015755L (no) 2002-01-23
DK1181018T3 (da) 2003-04-22
ZA200109692B (en) 2002-11-26
ATE234097T1 (de) 2003-03-15
PL196867B1 (pl) 2008-02-29
CN1196486C (zh) 2005-04-13
EA200101131A1 (ru) 2002-04-25
TWI263498B (en) 2006-10-11
MY127891A (en) 2006-12-29
NO320296B1 (no) 2005-11-21
HK1046366B (zh) 2005-07-29
GEP20033113B (en) 2003-11-25
MXPA01012124A (es) 2002-06-04
YU76701A (sh) 2005-07-19
HUP0201297A3 (en) 2005-09-28
EE04704B1 (et) 2006-10-16
IS2396B (is) 2008-08-15
BG106153A (bg) 2002-06-28
DE60001649D1 (de) 2003-04-17
UA59491C2 (uk) 2003-09-15
HUP0201297A2 (en) 2002-08-28
PL352826A1 (en) 2003-09-08
WO2000072847A1 (en) 2000-12-07
JP2003500449A (ja) 2003-01-07
GT200000081A (es) 2001-11-16
TNSN00112A1 (fr) 2005-11-10
DZ3049A1 (fr) 2004-03-27
RS50089B (sr) 2009-01-22
EP1181018B1 (en) 2003-03-12
HRP20010878A2 (en) 2003-06-30
AU4138500A (en) 2000-12-18
OA11946A (en) 2006-04-13
CO5170458A1 (es) 2002-06-27
CU23223B7 (es) 2007-08-30

Similar Documents

Publication Publication Date Title
BR0010990A (pt) Suspensão de ziprasidona
NL300877I2 (nl) obeticholzuur
AU1497692A (en) Sulfonamides and their medical use
MY136141A (en) Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
UY26851A1 (es) Derivados de la 4-fenilpiridina
ATE289478T1 (de) Ektoparasitizide wässrige suspensionsformulierungen von spinosynen
PT992509E (pt) Novos derivados macrolidos
DE69814735D1 (de) Carbazolcarboxamide als 5-HT1F Agonisten
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
TR199900730T2 (xx) S�v� alendronat form�lasyonlar�
AU2002358819A1 (en) Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
TR200300551T2 (tr) Agrokimyasal kompozisyon
ECSP003496A (es) Suspensión de ziprasidona
FR2801787B1 (fr) Nouvelles compositions cosmetiques pour ameliorer l'elasticite des tissus de soutien
ATE243219T1 (de) 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM ART. 8O, 11 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.